| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Joseph William Stauffer last filed a Form 4 in October 2018, as Chief Medical Officer at TVRD. Joseph William Stauffer's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 2,000 shares of TVRD. The TVRD filings lean toward selling, a net 9,442 shares.
Joseph William Stauffer has 5 Form 4 filings on record from August 2015 to October 2018, all as Chief Medical Officer at Tvardi Therapeutics (TVRD), 2015–2018.
The 6 reported transactions were 3 option or other derivative awards, 2 open-market sales and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $37K and 1 sale worth about $230K.
The only open-market purchase was 2,000 shares of TVRD at an average $18.60 on August 4, 2015, about $37K.
The only open-market sale was 11,442 shares of TVRD at an average $20.13 on October 17, 2018, about $230K.
Shares as reported in the last Form 4 for each company; the most recent is from October 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.